Estradiol modulation of neurotrophin receptor expression in female mouse basal forebrain cholinergic neurons in vivo

Endocrinology (United States)

Volumn 156, Issue 2, 2015, Pages 613-626

  Milne, Michael R ^a   Haug, Christopher A ^a   Ábrahám, István M ^a   Kwakowsky, Andrea ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CHOLINE ACETYLTRANSFERASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; NEUROTROPHIN; NEUROTROPHIN RECEPTOR P75; PROTEIN TYROSINE KINASE A; NERVE GROWTH FACTOR RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL AMYGDALA; CELL COUNT; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FOREBRAIN; IN VIVO STUDY; MAGNOCELLULAR NUCLEUS; MOUSE; NEUROPROTECTION; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPTUM PELLUCIDUM; SIGNAL TRANSDUCTION; ANIMAL; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; BASAL FOREBRAIN; CHOLINERGIC NEURONS; ESTRADIOL; FEMALE; MICE, KNOCKOUT; OVARIECTOMY; RECEPTORS, NERVE GROWTH FACTOR;

EID: 84921689989     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1669     Document Type: Article

References (81)

1. Baxter MG, Chiba AA. Cognitive functions of the basal forebrain. Curr Opin Neurobiol. 1999;9(2):178-183.
2. Jones BE. Activity, modulation and role of basal forebrain cholinergic neurons innervating the cerebral cortex. In: Laurent Descarries KK, Mircea S, eds. Progress in Brain Research. Vol 145. Amsterdam: Elsevier; 2004:157-169.
3. Page KJ, Sofroniew MV. The ascending basal forebrain cholinergic system. Prog Brain Res. 1996;107:513-522.
4. Buzsaki G, Bickford R, Ponomareff G, Thal L, Mandel R, Gage F. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci. 1988;8(11):4007-4026.
5. Pirch JH, Corbus MJ, Rigdon GC, Lyness WH. Generation of cortical event-related slow potentials in the rat involves nucleus basalis cholinergic innervation. Electroencephalogr Clin Neurophysiol. 1986;63(5):464-475.
6. Chiba A, Bucci D, Holland P, Gallagher M. Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing. J Neurosci. 1995;15(11):7315-7322.
7. Everitt B, Robbins T, Muir J. Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology. 1995;118(1):82-92.
8. Robertson HA, King GJ. Plasma concentrations of progesterone, oestrone, oestradiol-17- and of oestrone sulphate in the pig at implantation, during pregnancy and at parturition. J Reprod Fertil. 1974;40(1):133-141.
9. Merrill RC. Estriol: a review. Physiol Rev. 1958;38(3):463-480.
10. Brown JB. Urinary excretion of oestrogens during the menstrual cycle. Lancet. 1955;268(6859):320-323.
11. McEwen BS. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol. 2001;91(6):2785-2801.
12. Rapp PR, Morrison JH, Roberts JA. Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys. J Neurosci. 2003;23(13):5708-5714.
13. Ohm DT, Bloss EB, Janssen WG, et al. Clinically relevant hormone treatments fail to induce spinogenesis in prefrontal cortex of aged female rhesus monkeys. J Neurosci. 2012;32(34):11700-11705.
14. Hao J, Rapp PR, Leffler AE, et al. Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. J Neurosci. 2006;26(9):2571-2578.
15. Xu X, Zhang Z. Effects of estradiol benzoate on learning-memory behavior and synaptic structure in ovariectomized mice. Life Sci. 2006;79(16):1553-1560.
16. Liu F, Day M, Muniz LC, et al. Activation of estrogen receptor- regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci. 2008;11(3):334-343.
17. Wintermantel TM, Campbell RE, Porteous R, et al. Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron. 2006;52(2):271-280.
18. Koszegi Z, Szego E, Cheong RY, Tolod-Kemp E, Ábrahám IM. Postlesion estradiol treatment increases cortical cholinergic innervations via estrogen receptor- dependent nonclassical estrogen signaling in vivo. Endocrinology. 2011;152(9):3471-3482.
19. Horvath KM, Hartig W, Van der Veen R, et al. 17-Estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis. Neuroscience. 2002;110(3):489-504.
20. Bora SH, Liu Z, Kecojevic A, Merchenthaler I, Koliatsos VE. Direct, complex effects of estrogens on basal forebrain cholinergic neurons. Exp Neurol. 2005;194(2):506-522.
21. Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 1994;644(2):305-312.
22. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimers disease in women. Am J of Epidemiol. 1994;140(3): 256-261.
23. RoccaWA,Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res. 2011;1379:188-198.
24. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimers disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48(6):1517-1521.
25. Baldereschi M, Di Carlo A, Lepore V, et al. Estrogen-replacement therapy and Alzheimers disease in the Italian Longitudinal Study on Aging. Neurology. 1998;50(4):996-1002.
26. Gibbs RB, Aggarwal P. Estrogen and basal forebrain cholinergic neurons: implications for brain aging and Alzheimers disease-related cognitive decline. Horm Behav. 1998;34(2):98-111.
27. Ábrahám IM, Koszegi Z, Tolod-Kemp E, SzegoEM. Action of estrogen on survival of basal forebrain cholinergic neurons: promoting amelioration. Psychoneuroendocrinology. 2009;34(suppl 1): S104-S112.
28. Toran-Allerand CD, Miranda RC, Bentham WD, et al. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA. 1992;89(10):4668-4672.
29. Miranda RC, Sohrabji F, Toran-Allerand CD. Presumptive estrogen target neurons express mRNAs for both the neurotrophins and neurotrophin receptors: a basis for potential developmental interactions of estrogen with the neurotrophins. Mol Cell Neurosci. 1993;4(6): 510-525.
30. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10(3):381-391.
31. Alderson RF, Alterman AL, Barde Y-A, Lindsay RM. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron. 1990;5(3):297-306.
32. Hatanaka H, Nihonmatsu I, Tsukui H. Nerve growth factor promotes survival of cultured magnocellular cholinergic neurons from nucleus basalis of meynert in postnatal rats. Neurosci Lett. 1988; 90(1-2):63-68.
33. Friedman WJ, Ibáñez CF, Hallböök F, et al. Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol. 1993;119(1):72-78.
34. Knsel B, Winslow JW, Rosenthal A, et al. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA. 1991;88(3):961-965.
35. Gnahn H, Hefti F, Heumann R, Schwab ME, Thoenen H. NGFmediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain? Dev Brain Res. 1983;9(1):45-52.
36. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Annu Rev Neurosci. 1995;18:223-253.
37. Patapoutian A, Reichardt LF. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol. 2001;11(3):272-280.
38. Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropath Appl Neurobiol. 2003;29(3):211-230.
39. Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4(4):299-309.
40. Huang EJ, Reichardt LF. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem. 2003;72(1):609-642.
41. Bibel M, Hoppe E, Barde Y-A. Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR. EMBO J. 1999;18(3):616-622.
42. Vazquez ME, Ebendal T. Messenger RNAs for trk and the lowaffinity NGF receptor in rat basal forebrain. Neuroreport. 1991; 2(10):593-596.
43. Yan Q, Matheson C, Sun J, Radeke MJ, Feinstein SC, Miller JA. Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with Trk receptor expression. Exp Neurol. 1994;127(1):23-36.
44. Lee T-H, Kato H, Pan L-H, Ryu JH, Kogure K, Itoyama Y. Localization of nerve growth factor, trkA and p75 immunoreactivity in the hippocampal formation and basal forebrain of adult rats. Neuroscience. 1998;83(2):335-349.
45. Sobreviela T, Clary DO, Reichardt LF, Brandabur MM, Kordower JH, Mufson EJ. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J Comp Neurol. 1994;350(4):587-611.
46. Gibbs RB. Effects of ageing and long-term hormone replacement on cholinergic neurones in the medial septum and nucleus basalis magnocellularis of ovariectomized rats. J Neuroendocrinol. 2003;15(5): 477-485.
47. McMillan P, Singer C, Dorsa D. The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague-Dawley rat. J Neuroscience. 1996;16(5):1860-1865.
48. Tallini YN, Shui B, Greene KS, et al. BAC transgenic mice express enhanced green fluorescent protein in central and peripheral cholinergic neurons. Physiol Genomics. 2006;27:391-397.
49. Casanova E, Fehsenfeld S, Mantamadiotis T, et al. A CamKII iCre BAC allows brain-specific gene inactivation. Genesis. 2001;31(1): 37-42.
50. Bronson FH. The regulation of luteinizing hormone secretion by estrogen: relationships among negative feedback, surge potential, and male stimulation in juvenile, peripubertal, and adult female mice. Endocrinology. 1981;108(2):506-516.
51. Acosta-Cota SJ, Sánchez-Lpez A, Molina-Muñoz T, Gmez- Viquez NL, Centurin D. Evidence that chronic administration of 17-oestradiol decreases the vasopressor responses to adrenergic system stimulation in streptozotocin-diabetic female rats. Steroids. 2014;83:1-9.
52. OmotoY,ImamovO, WarnerM,Gustafsson J-A. Estrogen receptor- and imprinting of the neonatal mouse ventral prostate by estrogen. Proc Natl Acad Sci USA. 2005;102(5):1484-1489.
53. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor- and - mRNA in the rat central nervous system. J Comp Neurol. 1997;388(4):507-525.
54. Blurton-Jones MM, Roberts JA, Tuszynski MH. Estrogen receptor immunoreactivity in the adult primate brain: neuronal distribution and association with p75, trkA, and choline acetyltransferase. J Comp Neurol. 1999;405(4):529-542.
55. Paxinos G, Franklin KB. The mouse brain in stereotaxic coordinates. Vol 2. San Diego: Academic; 2001.
56. Gibbs RB. Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 1997;757(1):10-16.
57. Gibbs RB. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Res. 1998;787(2):259-268.
58. Gibbs RB. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp Neurol. 1998;151(2):289-302.
59. Gibbs RB, Wu D, Hersh LB, Pfaff DW. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp Neurol. 1994;129(1): 70-80.
60. Perez SE, Chen EY, Mufson EJ. Distribution of estrogen receptor- and- immunoreactive profiles in the postnatal rat brain. Brain Res Dev Brain Res. 2003;145(1):117-139.
61. Kppers E, Beyer C. Expression of estrogen receptor- and-mRNA in the developing and adult mouse striatum. Neurosci Lett. 1999; 276(2):95-98.
62. Grove-Strawser D, Boulware MI, Mermelstein PG. Membrane estrogen receptors activate the metabotropic glutamate receptors mGluR5 and mGluR3 to bidirectionally regulate CREB phosphorylation in female rat striatal neurons. Neuroscience. 2010;170(4): 1045-1055.
63. Mitra SW, Hoskin E, Yudkovitz J, et al. Immunolocalization of estrogen receptor in the mouse brain: comparison with estrogen receptor. Endocrinology. 2003;144(5):2055-2067.
64. Jezierski MK, Sohrabji F. Neurotrophin expression in the reproductively senescent forebrain is refractory to estrogen stimulation. Neurobiol Aging. 2001;22(2):309-319.
65. Spencer JL, Waters EM, Romeo RD, Wood GE, Milner TA, McEwen BS. Uncovering the mechanisms of estrogen effects on hippocampal function. Front Neuroendocrinol. 2008;29(2):219-237.
66. Gibbs RB, Pfaff DW. Effects of estrogen and fimbria/fornix transection on p75NGFR and ChAT expression in the medial septum and diagonal band of Broca. Exp Neurol. 1992;116(1):23-39.
67. Tinkler GP, Tobin JR, Voytko ML. Effects of two years of estrogen loss or replacement on nucleus basalis cholinergic neurons and cholinergic fibers to the dorsolateral prefrontal and inferior parietal cortex of monkeys. J Comp Neurol. 2004;469(4):507-521.
68. Shughrue PJ, Scrimo PJ, Merchenthaler I. Estrogen binding and estrogen receptor characterization (ER- and ER-) in the cholinergic neurons of the rat basal forebrain. Neuroscience. 2000; 96(1):41-49.
69. Klein R, Martin-Zanca D, BarbacidM,Parada LF. Expression of the tyrosine kinase receptor gene trkB is confined to the murine embryonic and adult nervous system. Development. 1990;109(4):845-850.
70. Dubal DB, Zhu H, Yu J, et al. Estrogen receptor, not, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci USA. 2001;98(4):1952-1957.
71. Mufson EJ, Li JM, Sobreviela T, Kordower JH. Decreased trkA gene expression within basal forebrain neurons in Alzheimers disease. Neuroreport. 1996;8(1):25-29.
72. Ginsberg SD,CheS,WuuJ, Counts SE,MufsonEJ.Downregulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimers disease. J Neurochem. 2006;97(2):475-487.
73. BrintonRD.Investigative models for determining hormone therapyinduced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann NY Acad Sci. 2005;1052(1):57-74.
74. Writing Group for the Womens Health Initiative I. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Womens Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
75. Azcoitia I, Arevalo M-A, De Nicola AF, Garcia-Segura LM. Neu roprotective actions of estradiol revisited. Trends Endocrinol Metab. 2011;22(12):467-473.
76. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer I. 2000;92(4):328-332.
77. Kwakowsky A, Koszegi Z, Cheong RY, Abraham IM. Neuroprotective effects of non-classical estrogen-like signaling activators: from mechanism to potential implications. CNS Neurol Disord Drug Targets. 2013;12(8):1219-1225.
78. Hu L, Yue Y, Zuo P-P, et al. Evaluation of neuroprotective effects of long-term low dose hormone replacement therapy on postmenopausal women brain hippocampus using magnetic resonance scanner. Chin Med Sci J. 2006;21(4):214-218.
79. LuineVN.Estradiol and cognitive function: past, present and future. Horm Behav. 2014;66(4):602-618.
80. Manson JE. Current recommendations: what is the clinician to do? Fertil Steril. 2014;101(4):916-921.
81. Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F. The Womens Health Initiative trial and related studies: 10 years later: a clinicians view. J Steroid Biochem Mol Biol. 2014;142:4-11.